Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipoprotein(a) Levels at Birth and in Early Childhood: The COMPARE Study
Nina Strandkjær, Malene Kongsgaard Hansen, Sofie Taageby Nielsen, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 107, Iss. 2, pp. 324-335
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
Florian Kronenberg, Samia Mora, Erik S.G. Stroes, et al.
European Heart Journal (2022) Vol. 43, Iss. 39, pp. 3925-3946
Open Access | Times Cited: 687
Lipoprotein(a) measurement issues: Are we making a mountain out of a molehill?
Florian Kronenberg
Atherosclerosis (2022) Vol. 349, pp. 123-135
Open Access | Times Cited: 91
A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice
Marlys L. Koschinsky, Archna Bajaj, Michael B. Boffa, et al.
Journal of clinical lipidology (2024) Vol. 18, Iss. 3, pp. e308-e319
Closed Access | Times Cited: 82
Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment
Stamatios Lampsas, Maria Xenou, Evangelos Oikonomou, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 969-969
Open Access | Times Cited: 69
Sex differences in lipids: A life course approach
Kirsten B. Holven, Jeanine E. Roeters van Lennep
Atherosclerosis (2023) Vol. 384, pp. 117270-117270
Open Access | Times Cited: 65
Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society
Florian Kronenberg, Samia Mora, Erik S.G. Stroes, et al.
Atherosclerosis (2023) Vol. 374, pp. 107-120
Open Access | Times Cited: 61
Recommendations of the Experts of the Polish Cardiac Society (PCS) and the Polish Lipid Association (PoLA) on the diagnosis and management of elevated lipoprotein(a) levels
Bożena Sosnowska, Janina Stępińska, Przemysław Mitkowski, et al.
Archives of Medical Science (2024) Vol. 20, Iss. 1, pp. 8-27
Open Access | Times Cited: 19
Lipoprotein(a) levels from childhood to adulthood: Data in nearly 3,000 children who visited a pediatric lipid clinic
Lotte M. de Boer, Michel H. Hof, Albert Wiegman, et al.
Atherosclerosis (2022) Vol. 349, pp. 227-232
Closed Access | Times Cited: 64
Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolaemia: An expert consensus statement from ERKNet and ESPN
M. Doortje Reijman, D. Meeike Kusters, Jaap W. Groothoff, et al.
Atherosclerosis (2024) Vol. 392, pp. 117525-117525
Open Access | Times Cited: 10
Lipoprotein(a) in youth and childhood as a marker of cardiovascular risk stratification: a meta-analysis
Irene Borzillo, Fabrizio D ́ascenzo, Emanuele Ravetti, et al.
Journal of Cardiovascular Medicine (2025)
Closed Access | Times Cited: 1
The Brussels International Declaration on Lipoprotein(a) Testing and Management
Florian Kronenberg, Nicola Bedlington, Zanfina Ademi, et al.
Atherosclerosis (2025), pp. 119218-119218
Open Access | Times Cited: 1
Lipoprotein(a)—60 Years Later—What Do We Know?
Anna Pasławska, Przemysław Tomasik
Cells (2023) Vol. 12, Iss. 20, pp. 2472-2472
Open Access | Times Cited: 18
Significance of lipids, lipoproteins, and apolipoproteins during the first 14–16 months of life
Sofie Taageby Nielsen, Rikke Mohr Lytsen, Nina Strandkjær, et al.
European Heart Journal (2023) Vol. 44, Iss. 42, pp. 4408-4418
Open Access | Times Cited: 14
Lipoprotein(a) serum concentrations in children in relation to body mass index, age and sex
Paulina Stürzebecher, Konstantin Uttinger, Mandy Vogel, et al.
Pediatric Research (2024) Vol. 96, Iss. 1, pp. 177-183
Open Access | Times Cited: 5
Lipoprotein(a): Role in atherosclerosis and new treatment options
Dragana Tomić Naglić, Mia Manojlović, Sladjana Pejaković, et al.
Biomolecules and Biomedicine (2023)
Open Access | Times Cited: 11
Rethinking Cardiovascular Risk: The Emerging Role of Lipoprotein(a) Screening
Victoria Clair, Francis Zirille, Edward A. Gill
American Journal of Preventive Cardiology (2025) Vol. 21, pp. 100945-100945
Open Access
Familial Hypercholesterolemia and Elevated Lipoprotein(a): Cascade Testing and Other Implications for Contextual Models of Care
Wann Jia Loh, Dick C. Chan, Pedro Mata, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 15
Evidence and Uncertainties on Lipoprotein(a) as a Marker of Cardiovascular Health Risk in Children and Adolescents
Simonetta Genovesi, Marco Giussani, Giulia Lieti, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1661-1661
Open Access | Times Cited: 9
Lipoprotein(a): a genetically determined risk factor for Cardiovascular disease
Santica M. Marcovina
Critical Reviews in Clinical Laboratory Sciences (2023) Vol. 60, Iss. 8, pp. 560-572
Closed Access | Times Cited: 9
Lipoprotein(a) throughout life in women
Pablo Corral, María G. Matta, Carlos A. Aguilar‐Salinas, et al.
American Journal of Preventive Cardiology (2024) Vol. 20, pp. 100885-100885
Open Access | Times Cited: 3
How Genetic Variants in Children with Familial Hypercholesterolemia Not Only Guide Detection, but Also Treatment
Sibbeliene E. van den Bosch, Willemijn E. Corpeleijn, Barbara A. Hutten, et al.
Genes (2023) Vol. 14, Iss. 3, pp. 669-669
Open Access | Times Cited: 5
Measuring lipoprotein(a) for cardiovascular disease prevention – in whom and when?
P. E. Thomas, Signe Vedel‐Krogh, Børge G. Nordestgaard
Current Opinion in Cardiology (2023) Vol. 39, Iss. 1, pp. 39-48
Closed Access | Times Cited: 5
Pharmacotherapy for children with elevated levels of lipoprotein(a): future directions
Lotte M. de Boer, Albert Wiegman, Daniel I. Swerdlow, et al.
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 14, pp. 1601-1615
Open Access | Times Cited: 7
Lipoprotein(a) in Children and Adolescents: Risk or Causal Factor for Cardiovascular Disease? A Narrative Review
Maria Elena Capra, Giacomo Biasucci, Giuseppe Banderali, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8817-8817
Open Access | Times Cited: 1
Lipoprotein(a) in interventional cardiology: identifying patients at highest risk of recurrent cardiovascular events through early recognition – a case based review
Mick Renkens, Casper F. Coerkamp, Lars S. Witte, et al.
Expert Review of Cardiovascular Therapy (2024) Vol. 22, Iss. 8, pp. 353-366
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top